s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
News

Texas Instruments Stock Higher On Q1 Results: Here’s A Look

April 23, 2024 George Levine No comments yet

Texas Instruments (TXN) shares pushed higher by 5.64% to $174.76 following the company’s better-than-expected first quarter financial results. Here’s how the company performed:

  • Q1 Revenue: $3.66 billion, beating the $3.611 billion estimate
  • Q1 EPS: $1.20, beating the $1.08 estimate

Texas Instruments also issued second quarter guidance. The company sees revenue to be in the range of $3.65 billion to $3.95 billion, versus the $3.77 billion estimate and EPS in the range of $1.05 to $1.25, versus the $1.16 estimate.

Our cash flow from operations of $6.3 billion for the trailing 12 months again underscored the strength of our business model, the quality of our product portfolio and the benefit of 300mm production. Free cash flow for the same period was $940 million.

Haviv Ilan, TI’s president and CEO

The company did note that revenue decreased 16%, from $4.379 billion, from the same quarter a year ago and 10% sequentially, as it experienced a decline in revenue across all end markets.

Texas Instruments stock experienced a spike in volume following the earnings announcement. The company has a 52-week low of $139.48 and a 52-week high of $188.12.

  • Earnings
  • Stocks

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity

March 3, 2025 Elisa Clay No comments yet

BioXcel Therapeutics (BTAI) announced that the U.S. Food and Drug Administration (FDA) has officially closed its inspection of a single site involved in the TRANQUILITY II Phase 3 trial under 21 C.F.R.20.64(d)(3). The FDA’s designation of “Voluntary Action Indicated” (VAI) signals that while minor issues may have been identified, no regulatory action is required, further […]

Featured, News, Trade Ideas

Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine

February 20, 2025 Elisa Clay No comments yet

Telomir Pharmaceuticals (NASDAQ: TELO) has achieved a major scientific breakthrough by stabilizing Silver(II) (Ag²⁺) using its proprietary compound, Telomir-1. This advancement overcomes a key challenge in silver-based medicine, unlocking new possibilities for antimicrobial treatments, wound care, and infection-resistant medical coatings. Silver(II) offers superior antibacterial action, faster wound healing, and immune-modulating properties compared to traditional Silver(I) […]

Featured, News, Trade Ideas

flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

February 14, 2025 Elisa Clay No comments yet

flyExclusive (NYSE American: FLYX), a leading provider of premium jet charter experiences, has entered into a definitive agreement to acquire the aviation business of Jet.AI (NASDAQ: JTAI). The deal will allow flyExclusive to expand its fleet and market presence while enabling Jet.AI to transition into a pure-play AI solutions company. Under the terms of the […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.